Coats' Disease in a Patient With Cornelia de Lange Syndrome: Management With Laser and Bevacizumab

J Pediatr Ophthalmol Strabismus. 2023 Jul-Aug;60(4):e45-e48. doi: 10.3928/01913913-20230619-03. Epub 2023 Jul 1.

Abstract

Cornelia de Lange syndrome is a congenital disorder with multisystem abnormalities including multiple ocular findings. The authors report a case of Coats' disease in a patient with Cornelia de Lange syndrome who was successfully treated with laser and intravitreal bevacizumab. This case demonstrates the importance of fluorescein angiography in making the diagnosis and directing treatment and the efficacy of combined laser with intravitreal anti-vascular endothelial growth factor therapy for persistent vascular leakage associated with Coats' disease in Cornelia de Lange syndrome. [J Pediatr Ophthalmol Strabismus. 2023;60(4):e45-e48.].

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • De Lange Syndrome* / complications
  • De Lange Syndrome* / diagnosis
  • De Lange Syndrome* / therapy
  • Humans
  • Lasers
  • Retinal Telangiectasis* / diagnosis
  • Retinal Telangiectasis* / therapy
  • Vascular Endothelial Growth Factor A

Substances

  • Bevacizumab
  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A